Annovis Bio press releases
The latest press releases from Annovis Bio (NYSE: ANVS), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Annovis Bio release within minutes of publication.
- Listing
- NYSE: ANVS
- Latest release
- Nov 5, 2026
- On this page
- 5 newest releases
Latest Annovis Bio press releases
- Annovis Announces Pricing of $21.0 Million Public Offering
MALVERN, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy,…
- Annovis Announces Launch of Proposed Public Offering
MALVERN, Pa., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy,…
- Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy,…
The first 3 are open to everyone. A free account shows the rest and emails you the next Annovis Bio release the minute it is out.
PPN World is independent and not affiliated with Annovis Bio. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Annovis Bio press releases?+
How do I get an alert when Annovis Bio publishes a press release?+
Is this Annovis Bio's official newsroom?+
Know the minute Annovis Bio publishes
Watch Annovis Bio, its competitors and its sector in one live feed, with email alerts — on the free plan.